Award winner profile
OncoGenomX Inc.
This organisation has earned distinction among peers worldwide. They represent the benchmark that others measure themselves against.
OncoGenomX Inc.
Global 100 - 2025
OncoGenomX reimagines precision oncology with AI-powered oncology software for tumor assaying, delivering actionable clinical intelligence for confident R&D or therapy decisions, boosting success, improving outcomes, and reducing costs.
Most Innovative Oncology Software Company 2025 – Europe
Explore their work directly
Visit their website to see what they have built and understand their approach firsthand.